PEDIATRICS

FEBRERO 2008


 

Abstract 1 of 18 back

 

Mercury Level  in Newborns and Infants After Receipt of Thimerosal-Containing Vaccines

Michael E. Pichichero, MDa, Angela Gentile, MDb, Norberto Giglio, MDb, Veronica Umido, MDb, Thomas Clarkson, PhDc, Elsa Cernichiari, MSc, Grazyna Zareba, PhDc, Carlos Gotelli, PhDd, Mariano Gotelli, PhDd, Lihan Yan, MSe and John Treanor, MDa

a Department of Microbiology/Immunology, Pediatrics, and Medicine, University of Rochester, Rochester, New York
b Department of Epidemiology, R. Gutierrez Children's Hospital, Buenos Aires, Argentina
c Department of Environmental Medicine, University of Rochester, Rochester, New York
d Center of Toxicology Research, Buenos Aires, Argentina
e EMMES Corp, Rockville, Maryland

OBJECTIVES. Thimerosal is a mercurial preservative that was widely used in multidose vaccine vials in the United States and Europe until 2001 and continues to be used in many countries throughout the world. We conducted a pharmacokinetic study to assess blood levels and elimination of ethyl mercury after vaccination of infants with thimerosal-containing vaccines.

METHODS. Blood, stool, and urine samples were obtained before vaccination and 12 hours to 30 days after vaccination from 216 healthy children: 72 newborns (group 1), 72 infants aged 2 months (group 2), and 72 infants aged 6 months (group 3). Total mercury levels were measured by atomic absorption. Blood mercury pharmacokinetics were calculated by pooling the data on the group and were based on a 1-compartment first-order pharmacokinetics model.

RESULTS. For groups 1, 2, and 3, respectively, (1) mean ± SD weights were 3.4 ± 0.4, 5.1 ± 0.6, and 7.7 ± 1.1 kg; (2) maximal mean ± SD blood mercury levels were 5.0 ± 1.3, 3.6 ± 1.5, and 2.8 ± 0.9 ng/mL occurring at 0.5 to 1 day after vaccination; (3) maximal mean ± SD stool mercury levels were 19.1 ± 11.8, 37.0 ± 27.4, and 44.3 ± 23.9 ng/g occurring on day 5 after vaccination for all groups; and (4) urine mercury levels were mostly nondetectable. The blood mercury half-life was calculated to be 3.7 days and returned to prevaccination levels by day 30.

CONCLUSIONS. The blood half-life of intramuscular ethyl mercury from thimerosal in vaccines in infants is substantially shorter than that of oral methyl mercury in adults. Increased mercury levels were detected in stools after vaccination, suggesting that the gastrointestinal tract is involved in ethyl mercury elimination. Because of the differing pharmacokinetics of ethyl and methyl mercury, exposure guidelines based on oral methyl mercury in adults may not be accurate for risk assessments in children who receive thimerosal-containing vaccines.


Key Words: thimerosal • vaccine • neurotoxicity • ethyl mercury

Abbreviations: Hib—Haemophilus influenzae type b • HBV—hepatitis B virus • CI—confidence interval • DTwP—diphtheria–tetanus–whole-cell pertussis • CVAFS—cold-vapor atomic fluorescence spectrophotometry • GGT—{gamma}-glutamyl transpeptidase


Accepted Jul 16, 2007.

[Full Text of Pichichero et al.] [Reprint (PDF) Version of Pichichero et al.]


Abstract 2 of 18 back

 

Fathers’ Experiences in the Neonatal Intensive Care Unit: A Search for Control

Vincent Arockiasamy, MRCPIa, Liisa Holsti, PhDb,c,d and Susan Albersheim, MD, PhDa,d

a Departments of Pediatrics
b Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, British Columbia, Canada
c Centre for Community Child Health Research, Child and Family Research Institute, Vancouver, British Columbia, Canada
d B.C. Children's and Women's Hospitals, Vancouver, British Columbia, Canada

OBJECTIVE. This qualitative study aimed at understanding the experiences of fathers of very ill neonates in the NICU.

METHODS. Sixteen fathers of very ill and/or very preterm infants who had been in the NICU for >30 days were interviewed by a male physician. Fathers were asked about their level of comfort with or concerns about staff communication regarding their infant, about accessing information, and about more general perceptions of their experience in the neonatal intensive care unit. Interviews were audiotaped and transcribed for analysis. Coding used content analysis with construction of themes by 3 researchers.

RESULTS. The overarching theme for fathers was a sense of lack of control. Their world view, as a "backdrop" theme, provided context for all of the themes. Four other interrelated subthemes were identified, including information; communication, particularly with the health care team; fathers’ various roles; and external activities. Fathers reported that relationships with friends/family/health care team, receiving information consistently, and receiving short written materials on common conditions were ways of giving them support. The fathers said that speaking to a male physician was a positive and useful experience.

CONCLUSIONS. Fathers experience a sense of lack of control when they have an extremely ill infant in the NICU. Specific activities help fathers regain a sense of control and help them fulfill their various roles of protectors, fathers, partners, and breadwinners. Understanding these experiences helps the health care team offer targeted supports for fathers in the NICU.


Key Words: preterm infant • fathers • stress • NICU


Accepted Jun 20, 2007.

[Full Text of Arockiasamy et al.] [Reprint (PDF) Version of Arockiasamy et al.]


Abstract 3 of 18 back

 

Effect of Late-Preterm Birth and Maternal Medical Conditions on Newborn Morbidity Risk

Carrie K. Shapiro-Mendoza, PhD, MPHa, Kay M. Tomashek, MD, MPHa, Milton Kotelchuck, PhD, MPHb, Wanda Barfield, MD, MPHa, Angela Nannini, PhDc, Judith Weiss, ScDb and Eugene Declercq, PhDb

a Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
b Department of Maternal and Child Health, Boston University School of Public Health, Boston, Massachusetts
c Massachusetts Department of Public Health, Bureau of Family and Community Health, and Northeastern University, Boston, Massachusetts

OBJECTIVES. Late-preterm infants (34–36 weeks’ gestation) account for nearly three quarters of all preterm births in the United States, yet little is known about their morbidity risk. We compared late-preterm and term (37–41 weeks’ gestation) infants with and without selected maternal medical conditions and assessed the independent and joint effects of these exposures on newborn morbidity risk.

METHODS. We used 1998–2003, population-based, Massachusetts birth and death certificates data linked to infant and maternal hospital discharge records from the Massachusetts Pregnancy to Early Life Longitudinal data system. Newborn morbidity risks that were associated with gestational age and selected maternal medical conditions, both independently and as joint exposures, were estimated by calculating adjusted risk ratios. A new measure of newborn morbidity that was based on hospital discharge diagnostic codes, hospitalization duration, and transfer status was created to define newborns with and without life-threatening conditions. Eight selected maternal medical conditions were assessed (hypertensive disorders of pregnancy, diabetes, antepartum hemorrhage, lung disease, infection, cardiac disease, renal disease, and genital herpes) in relation to newborn morbidity.

RESULTS. Our final study population included 26170 infants born late preterm and 377638 born at term. Late-preterm infants were 7 times more likely to have newborn morbidity than term infants (22% vs 3%). The newborn morbidity rate doubled in infants for each gestational week earlier than 38 weeks. Late-preterm infants who were born to mothers with any of the maternal conditions assessed were at higher risk for newborn morbidity compared with similarly exposed term infants. Late-preterm infants who were exposed to antepartum hemorrhage and hypertensive disorders of pregnancy were especially vulnerable.

CONCLUSIONS. Late-preterm birth and, to a lesser extent, maternal medical conditions are each independent risk factors for newborn morbidity. Combined, these 2 factors greatly increased the risk for newborn morbidity compared with term infants who were born without exposure to these risks.


Key Words: preterm birth • near-term infant • late-preterm infant • morbidity • maternal health

Abbreviations: HDP—hypertensive disorders of pregnancy • PELL—Pregnancy to Early Life Longitudinal • ICD-9-CM—International Classification of Diseases, Ninth Revision, Clinical Modification • GED—general equivalency diploma • cRR—crude risk ratio • aRR—adjusted risk ratio • CI—confidence interval


Accepted Jun 19, 2007.

[Full Text of Shapiro-Mendoza et al.] [Reprint (PDF) Version of Shapiro-Mendoza et al.]


Abstract 4 of 18 back

 

Prevention and 18-Month Outcomes of Serious Pulmonary Hemorrhage in Extremely Low Birth Weight Infants: Results From the Trial of Indomethacin Prophylaxis in Preterms

Khalid Alfaleh, MDa, John A. Smyth, MDb, Robin S. Roberts, MScc, Alfonso Solimano, MDb, Elizabeth V. Asztalos, MDd, Barbara Schmidt, MDa,c for the Trial of Indomethacin Prophylaxis in Preterms Investigators

a Departments of Pediatrics
c Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
b Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada
d Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada

OBJECTIVES. A patent ductus arteriosus is a risk factor for pulmonary hemorrhage; however, despite halving the incidence of patent ductus arteriosus, indomethacin prophylaxis did not reduce the rate of pulmonary hemorrhage in the Trial of Indomethacin Prophylaxis in Preterms. Inclusion of mild bleeds after trauma to the upper airways may have masked a beneficial drug effect. Using the Trial of Indomethacin Prophylaxis in Preterms database, we studied the effect of prophylactic indomethacin on the prevention of serious hemorrhages in extremely low birth weight infants. We also compared the 18-month outcomes of infants with and without a serious pulmonary bleed.

METHODS. Pulmonary hemorrhage was classified as serious when it was treated with increased ventilator support, a higher concentration of oxygen, or transfusion of blood products. The cumulative risk for serious pulmonary hemorrhage was estimated for the first week of life and for the entire NICU stay. Poor outcome at a corrected age of 18 months was death or survival with cerebral palsy, cognitive delay, blindness, and/or deafness.

RESULTS. A total of 123 (10.2%) of 1202 infants developed a serious pulmonary hemorrhage. During week 1, prophylactic indomethacin reduced the risk for serious pulmonary hemorrhage by 35%; however, during the entire NICU stay, the risk for such hemorrhages was decreased by only 23%. A reduced risk for patent ductus arteriosus explained 80% of the beneficial effect of prophylactic indomethacin on serious pulmonary bleeds. The risks for death or for survival with neurosensory impairment were doubled after a serious pulmonary hemorrhage.

CONCLUSIONS. Extremely low birth weight infants with serious pulmonary hemorrhage have an increased risk for poor long-term outcome. Prophylactic indomethacin reduces the rate of early serious pulmonary hemorrhage, mainly through its action on patent ductus arteriosus. Prophylactic indomethacin is less effective in preventing serious pulmonary hemorrhages that occur after the first week of life.


Key Words: extremely low birth weight • pulmonary hemorrhage • indomethacin prophylaxis

Abbreviations: PDA—patent ductus arteriosus • TIPP—Trial of Indomethacin Prophylaxis in Preterms • ELBW—extremely low birth weight


Accepted Jul 19, 2007.

[Full Text of Alfaleh et al.] [Reprint (PDF) Version of Alfaleh et al.]


Abstract 5 of 18 back

 

Effects of Basic Developmental Care on Neonatal Morbidity, Neuromotor Development, and Growth at Term Age of Infants Who Were Born at <32 Weeks

Celeste M. Maguire, MSa, Sylvia Veen, MD, PhDa, Arwen J. Sprij, MDb, Saskia Le Cessie, PhDc, Jan M. Wit, MD, PhDa, Frans J. Walther, MD, PhDa on behalf of the Leiden Developmental Care Project

a Subdivision of Neonatology, Department of Pediatrics
c Department of Medical Statistics, Leiden University Medical Center, Leiden, Netherlands
b Subdivision of Neonatology, Department of Pediatrics, Haga Hospital, Juliana Children's Hospital, The Hague, Netherlands

OBJECTIVE. The goal of this study was to investigate the effect of basic elements of developmental care (incubator covers and positioning aids) on days of respiratory support and intensive care, growth, and neuromotor development at term age in infants who were born at <32 weeks’ gestation.

METHODS. Infants were randomly assigned within 48 hours of birth to the developmental care group or the standard care control group (no covers or nests). The intervention continued until the infant either was transferred to a regional hospital or was discharged from the hospital. Length, weight, and head circumference were measured (bi)weekly and at term age. Neuromotor development was defined as definitely abnormal (presence of a neonatal neurologic syndrome, such as apathy or hyperexcitability, hypotonia or hypertonia, hyporeflexia or hyperreflexia, hypokinesia or hyperkinesia, or a hemisyndrome), mildly abnormal (presence of only part of such a syndrome), or normal.

RESULTS. A total of 192 infants were included (developmental care: 98; control: 94). Thirteen infants (developmental care: 7; control: 6) were excluded according to protocol (admitted for less than or died within the first 5 days: n = 12; taken out at parents’ request: n = 1), which left a total of 179 infants who met inclusion criteria. In-hospital mortality was 12 (13.2%) of 91 in the developmental care group and 8 (9.1%) of 88 in the control group. There was no significant difference in the number of days of respiratory support, number of intensive care days, short-term growth, or neuromotor developmental outcome at term age between the developmental care and control groups. Duration of the intervention, whether only during the intensive care period or until hospital discharge, had no significant effect on outcome.

CONCLUSIONS. Providing basic developmental care in the NICU had no effect on short-term physical and neurologic outcomes in infants who were born at <32 weeks’ gestation.


Key Words: preterm infants • developmental care • NIDCAP • growth • respiratory support • intensive care • neurodevelopment

Abbreviations: DC—developmental care • NIDCAP—Newborn Individualized Developmental Care and Assessment Program • RCT—randomized, controlled trial • CPAP—continuous positive airway pressure • IVH—intraventricular hemorrhage


Accepted Jun 18, 2007.

[Full Text of Maguire et al.] [Reprint (PDF) Version of Maguire et al.]


Abstract 6 of 18 back

 

Pepsin, a Marker of Gastric Contents, Is Increased in Tracheal Aspirates From Preterm Infants Who Develop Bronchopulmonary Dysplasia

Sabeena Farhath, MDa, Zhaoping He, PhDa, Tarek Nakhla, MDb, Judy Saslow, MDb, Sam Soundar, PhDa, Jeanette Camacho, MDc, Gary Stahl, MDb, Stephen Shaffer, MDa, Devendra I. Mehta, MDd and Zubair H. Aghai, MDb

a Division of Gastroenterology and Nutrition and Nemours Biomedical Research, Alfred I. duPont Hospital for Children, Wilmington, Delaware
b Departments of Pediatrics/Neonatology
c Pathology, Cooper University Hospital-UMDNJ-Robert Wood Johnson Medical School, Camden, New Jersey
d Division of Gastroenterology and Nutrition, Nemours Children's Clinic, Orlando, Florida

OBJECTIVE. The objective of this study was to study the association between pepsin in tracheal aspirate samples and the development of bronchopulmonary dysplasia in preterm infants.

METHODS. Serial tracheal aspirate samples were collected during the first 28 days from mechanically ventilated preterm neonates. Bronchopulmonary dysplasia was defined as the need for supplemental oxygen at 36 weeks’ postmenstrual age. An enzymatic assay with a fluorescent substrate was used to detect pepsin. Total protein was measured by the Bradford assay to correct for the dilution during lavage. Immunohistochemistry using antibody against human pepsinogen was performed in 10 lung tissue samples from preterm infants.

RESULTS. A total of 256 tracheal aspirate samples were collected from 59 preterm neonates. Pepsin was detected in 234 (91.4%) of 256 of the tracheal aspirate samples. Twelve infants had no bronchopulmonary dysplasia, 31 infants developed bronchopulmonary dysplasia, and 16 infants died before 36 weeks’ postmenstrual age. The mean pepsin concentration was significantly lower in infants with no bronchopulmonary dysplasia compared with those who developed bronchopulmonary dysplasia or developed bronchopulmonary dysplasia/died before 36 weeks’ postmenstrual age. Moreover, the mean pepsin level was significantly higher in infants with severe bronchopulmonary dysplasia compared with moderate bronchopulmonary dysplasia. The mean pepsin level in tracheal aspirate samples from the first 7 days was also lower in infants with no bronchopulmonary dysplasia compared with those who developed bronchopulmonary dysplasia or developed bronchopulmonary dysplasia/died before 36 weeks’ postmenstrual age. Pepsinogen was not localized in the lung tissues by immunohistochemistry.

CONCLUSION. The concentration of pepsin was increased in the tracheal aspirate of preterm infants who developed bronchopulmonary dysplasia or died before 36 weeks’ postmenstrual age. Recovery of pepsin in tracheal aspirate samples is secondary to gastric aspiration, not by hematogenous spread or local synthesis in the lungs. Chronic aspiration of gastric contents may contribute in the pathogenesis of bronchopulmonary dysplasia.


Key Words: gastric aspiration • gastroesophageal reflux • pepsin • preterm infants • bronchopulmonary dysplasia

Abbreviations: BPD—bronchopulmonary dysplasia • GER—gastroesophageal reflux • TA—tracheal aspirate • PMA—postmenstrual age • GA—gestational age • BSA—bovine serum albumin


Accepted Jul 6, 2007.

[Full Text of Farhath et al.] [Reprint (PDF) Version of Farhath et al.]


Abstract 7 of 18 back

 

Baby Care Products: Possible Sources of Infant Phthalate Exposure

Sheela Sathyanarayana, MD, MPHa,b, Catherine J. Karr, MD, PhDa,b, Paula Lozano, MD, MPHb, Elizabeth Brown, PhDc, Antonia M. Calafat, PhDd, Fan Liu, MSe and Shanna H. Swan, PhDe

a Departments of Occupational and Environmental Health Sciences
b Pediatrics
c Biostatistics, University of Washington, Seattle, Washington
d Centers for Disease Control and Prevention, Atlanta, Georgia
e Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York

OBJECTIVES. Phthalates are man-made chemicals found in personal care and other products. Recent studies suggest that some phthalates can alter human male reproductive development, but sources of infant exposure have not been well characterized. We investigated the relationship between phthalate metabolite concentrations in infant urine and maternal reported use of dermally applied infant care products.

METHODS. We measured 9 phthalate metabolites in 163 infants who were born in 2000–2005. An infant was considered to have been exposed to any infant care product that the mother reported using on her infant within 24 hours of urine collection. Results of multiple linear regression analyses are reported as the ratio of metabolite concentrations (with 95% confidence intervals) in exposed and unexposed infants. We standardized concentrations by forming z scores and examined combined exposure to multiple metabolites.

RESULTS. In most (81%) infants, ≥7 phthalate metabolites were above the limit of detection. Exposure to lotion was predictive of monoethyl phthalate and monomethyl phthalate concentrations, powder of monoisobutyl phthalate, and shampoo of monomethyl phthalate. Z scores increased with number of products used. Most associations were stronger in younger infants.

CONCLUSIONS. Phthalate exposure is widespread and variable in infants. Infant exposure to lotion, powder, and shampoo were significantly associated with increased urinary concentrations of monoethyl phthalate, monomethyl phthalate, and monoisobutyl phthalate, and associations increased with the number of products used. This association was strongest in young infants, who may be more vulnerable to developmental and reproductive toxicity of phthalates given their immature metabolic system capability and increased dosage per unit body surface area.


Key Words: phthalate • infant • environmental exposure • baby care product

Abbreviations: DEHP—di-2-ethylhexyl phthalate • DBP—dibutyl phthalate • MEP—monoethyl phthalate • MBP—mono-n-butyl phthalate • MBzP—monobenzyl phthalate • MiBP—monoisobutyl phthalate • DiNP—di-isononyl phthalate • SFFI—Study for Future Families, Phase I • SFFII—Study for Future Families, Phase II • MMP—monomethyl phthalate • MCPP—mono-3-carboxypropyl phthalate • DnOP—di-n-octyl phthalate • MEHP—mono-2-ethylhexyl phthalate • MEHHP—mono-2-ethyl-5-hydroxyhexyl phthalate • MEOHP—mono-2-ethyl-5-oxohexyl phthalate • LOD—limit of detection • LPMC—log phthalate metabolite concentration • CI—confidence interval • NHANES—National Health and Nutrition Examination Survey • DEP—diethyl phthalate • BBzP—butylbenzyl phthalate


Accepted Jul 16, 2007.

[Full Text of Sathyanarayana et al.] [Reprint (PDF) Version of Sathyanarayana et al.]


Abstract 8 of 18 back

 

Population-Based Assessments of Ophthalmologic and Audiologic Follow-up in Children With Very Low Birth Weight Enrolled in Medicaid: A Quality-of-Care Study

C. Jason Wang, MD, PhDa,b,d, Marc N. Elliott, PhDb, Elizabeth A. McGlynn, PhDb, Robert H. Brook, MD, ScDb,c,e and Mark A. Schuster, MD, PhDb,d,e

a Departments of Pediatrics and Maternal and Child Health, Boston Medical Center and Boston University Schools of Medicine and Public Health, Boston, Massachusetts
b Rand Health, Santa Monica, California
c Division of General Internal Medicine, Department of Medicine
d Department of Pediatrics, Mattel Children's Hospital, David Geffen School of Medicine
e Department of Health Services, School of Public Health, University of California, Los Angeles, California

OBJECTIVE. The purpose of our work was to determine whether children with very low birth weight (<1500 g) who are at high risk for vision and hearing problems and enrolled in Medicaid receive recommended follow-up vision and hearing services and to examine predictors of services.

PATIENTS AND METHODS. We conducted a retrospective analysis of 2182 children born in South Carolina from 1996 to 1998 with birth weights of 401 to 1499 g, gestations of ≥24 weeks, and survival of ≥90 days of life. Receipt of services for Medicaid-enrolled children was assessed by using a linked data set that included files from vital records, death certificates, Medicaid, Chronic Rehabilitative Services, and the Early Intervention Program. We assessed the receipt of hearing rehabilitation by 6 months of age for children with nonconductive hearing loss and routine ophthalmologic examination between ages of 1 and 2 years for all children with very low birth weight. Multivariate logistic regression was restricted to ophthalmologic examinations because of sample size.

RESULTS. Among children with very low birth weight with nonconductive hearing loss, 20% received hearing rehabilitation by 6 months of age. Twenty-three percent of children with very low birth weight received an ophthalmologic examination between the ages of 1 and 2 years. Limiting our analysis to children <1000 g or extending the measurement period to 7 months (hearing) and age 3 years (vision) did not substantially increase the percentage of children receiving the services. The receipt of an ophthalmologic examination was associated positively with Medicaid enrollment by the time of hospital discharge and birth in a level-3 hospital and negatively associated with higher birth weight, an Apgar score of ≥7, and black maternal race. Among children born at <1000 g, all of whom were eligible for the Early Intervention Program, the receipt of an ophthalmologic examination was positively associated with program enrollment.

CONCLUSIONS. There is a shortfall in the provision of critical services for children with very low birth weight. These findings reinforce the Institute of Medicine's concerns regarding inadequate outcome data and health care services for preterm infants and support the importance of enrollment in the Early Intervention Program for children with very low birth weight.


Key Words: low birth weight • quality of care • early intervention

Abbreviations: VLBW—very low birth weight • ELBW—extremely low birth weight • ROP—retinopathy of prematurity • EIP—Early Intervention Program • CRS—chronic rehabilitative services • ICD-9—International Classification of Diseases, Ninth Revision • OR—odds ratio


Accepted Jul 16, 2007.

[Full Text of Wang et al.] [Reprint (PDF) Version of Wang et al.]


Abstract 9 of 18 back

 

Chlamydia trachomatis as a Cause of Neonatal Conjunctivitis in Dutch Infants

Ingrid G.I.J.G. Rours, MD, MMeda, Margaret R. Hammerschlag, MDb, Alewijn Ott, MD, PhDc, Tjeerd J.T.H.N. De Faber, MDd, Henri A. Verbrugh, MDc, Ronald de Groot, MDa and Roel P. Verkooyen, PhDc

a Department of Pediatrics, Sophia Children's Hospital
c Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam, Netherlands
b Department of Pediatrics, Division of Infectious Diseases, State University of New York Downstate Medical Center, Brooklyn, New York
d Department of Ophthalmology, Rotterdam Eye Hospital, Rotterdam, Netherlands

BACKGROUND. Chlamydia trachomatis is the most common sexually transmitted pathogen in adults, which at delivery may be transmitted from mother to child and cause conjunctivitis and pneumonia. In the Netherlands, prenatal chlamydial screening and treatment of pregnant women is not routine practice. The contribution of C trachomatis to neonatal ophthalmic disease has not been studied in the Netherlands and remains unclear.

METHODS. At the Sophia Children's Hospital and Rotterdam Eye Hospital, 2 cohorts of infants <3 months of age presenting with conjunctivitis were studied, 1 retrospectively (July 1996 to July 2001) and 1 prospectively (September 2001 to September 2002). Laboratory diagnosis was based on bacterial culture and polymerase chain reaction for C trachomatis.

RESULTS. C trachomatis was detected in 27 (64%) of 42 retrospectively studied infants and 14 (61%) of 23 prospectively studied infants. Mucopurulent discharge was present in 35 (95%) of 37, swelling of the eyes in 27 (73%) of 37, conjunctival erythema in 24 (65%) of 37, respiratory symptoms in 14 (38%) of 37, and feeding problems in 5 (14%) of 37 infants respectively. Before microbiological diagnosis, general practitioners prescribed antichlamydial antibiotics locally to 5 (12%) of 41 and systemically to 4 (10%) of 41 infants who tested positive for chlamydia, and ophthalmologists prescribed to 21 (51%) of 41 and 7 (17%) of 41, respectively.

CONCLUSIONS. C trachomatis was the major cause of bacterial conjunctivitis in this population. Clinically, differentiation from other pathogens was not possible. Many infants who tested positive for chlamydia did not receive appropriate antibiotic treatment.


Key Words: Chlamydia trachomatis • neonatal conjunctivitis

Abbreviations: REH—Rotterdam Eye Hospital • SCH—Sophia Children's Hospital • GP—general practitioner • PCR—polymerase chain reaction


Accepted Jun 25, 2007.

[Full Text of Rours et al.] [Reprint (PDF) Version of Rours et al.]


Abstract 10 of 18 back

 

Analgesic Properties of Oral Sucrose During Routine Immunizations at 2 and 4 Months of Age

Linda A. Hatfield, PhD, CNNPa, Maryellen E. Gusic, MDb, Anne-Marie Dyer, MSc and Rosemary C. Polomano, PhD, RN, FAANd

a Pennsylvania State University School of Nursing, College of Health and Human Development, University Park, Pennsylvania
b Division of General Pediatrics, Pennsylvania State University College of Medicine
c Division of Biostatistics, Public Health Sciences, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania
d Biobehavioral Research Center, University of Pennsylvania School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania

OBJECTIVE. The purpose of this work was to evaluate the analgesic properties of oral sucrose during routine immunizations in infants at 2 and 4 months of age.

PATIENTS AND METHODS. A prospective, randomized, placebo-controlled clinical trial was conducted at a pediatric ambulatory care clinic. One-hundred healthy term infants scheduled to receive routine immunizations were recruited, randomly stratified into 2- or 4-month study groups, and further randomly assigned to receive 24% oral sucrose and pacifier or the sterile water control solution. The study preparations were administered 2 minutes before the combined diphtheria-tetanus-acellular pertussis, inactivated polio vaccine, and hepatitis B vaccine. Haemophilus influenzae type b vaccine was administered 3 minutes after the combined injection, followed by the pneumococcal conjugate vaccine, 2 minutes after the H influenzae type b injection. The University of Wisconsin Children's Hospital Pain Scale measured serial acute pain responses for the treatment and control groups at baseline and 2, 5, 7, and 9 minutes after solution administration. Repeated-measures analysis of variance examined between-group differences and within-subject variability of treatment effect on overall pain scores.

RESULTS. Two- and 4-month-old infants receiving oral sucrose (n = 38) displayed reductions in pain scores 2 minutes after solution administration compared with 2- and 4-month-old infants in the placebo group (n = 45). Between-group comparisons for the oral sucrose and placebo groups showed lower pain responses at 5, 7, and 9 minutes after solution administration. The oral sucrose and placebo groups demonstrated their highest mean pain score at 7 minutes, with a mean pain score of 3.8 and 4.8, respectively. At 9 minutes, the placebo group had a mean pain score of 2.91 whereas the mean pain score for the oral sucrose group returned to near baseline, reflecting a 78.5% difference in mean pain score (oral sucrose – placebo) relative to the placebo mean.

CONCLUSIONS. Oral sucrose is an effective, easy-to-administer, short-acting analgesic for use during routine immunizations.


Key Words: immunizations • infant • pain • sucrose

Abbreviations: RCT—randomized, controlled trial • NNS—nonnutritive sucking • UWCH—University of Wisconsin Children's Hospital • CI—confidence interval • NNT—number needed to treat


Accepted Jul 19, 2007.

[Full Text of Hatfield et al.] [Reprint (PDF) Version of Hatfield et al.]


Abstract 11 of 18 back

 

Evaluating Loss to Follow-up in Newborn Hearing Screening in Massachusetts

Chia-ling Liu, RN, MPH, ScD, Janet Farrell, BA, Jessica R. MacNeil, MPH, Sarah Stone, BBA and Wanda Barfield, MD, MPH

Center for Community Health, Massachusetts Department of Public Health, Boston, Massachusetts

OBJECTIVE. The purpose of this work was to examine loss to follow-up on the use of diagnostic or intervention services for Massachusetts infants and children screened or diagnosed with hearing loss and risk factors for becoming lost to follow-up.

METHODS. We used data from the Massachusetts Childhood Hearing Data System and Early Intervention Information System. We calculated the percent use of audiologic evaluation for Massachusetts infants born in 2002–2003 who did not pass hearing screening and Early Intervention services for those with hearing loss. We generated crude and adjusted relative risks, as well as confidence intervals, to estimate associations of maternal and infant factors with the use of audiologic evaluation and early intervention services. Factors evaluated included child's birth weight and hearing screening or diagnostic results and maternal age, race or ethnicity, marital status, smoking status during pregnancy, educational attainment, health insurance, and residence region.

RESULTS. In 2002–2003, 11% of Massachusetts children who did not pass hearing screening became lost to follow-up on the audiologic evaluation, and 25% of those with hearing loss did not receive early intervention services. Children were at higher risk of becoming lost to follow-up on audiologic evaluation if their mothers were nonwhite, covered by public insurance, smokers during pregnancy, or residing in western, northeastern, or southeastern Massachusetts compared with those in the Boston region. Of children with hearing loss, those with a unilateral or mild or moderate degree of hearing loss, normal birth weight, or living in the southeastern or Boston region were more likely to go without early intervention services.

CONCLUSIONS. Massachusetts has excellent follow-up rates overall. Our analyses allow the program to prioritize limited resources to subgroups of infants who are at high risk of becoming lost to follow-up.


Key Words: early hearing detection and intervention • lost to follow-up • early intervention

Abbreviations: MDPH—Massachusetts Department of Public Health • ADC—audiologic diagnostic center • EI—Early Intervention • IFSP—Individualized Family Service Plan • UNHSP—Universal Newborn Hearing Screening Program • EHDI—Early Hearing Detection and Intervention • CHDS—Childhood Hearing Data System • EIIS—Early Intervention Information System • EBC—electronic birth certificate • AE—audiologic evaluation report • FIR—family intake record • ABR—auditory brainstem response • OAE—otoacoustic emission • aRR—adjusted relative risk • CI—confidence interval


Accepted Jul 5, 2007.

[Full Text of Liu et al.] [Reprint (PDF) Version of Liu et al.]


Abstract 12 of 18 back

 

Effect of a Short Course of Prednisolone in Infants With Oxygen-Dependent Bronchopulmonary Dysplasia

Anita Bhandari, MDa, Craig M. Schramm, MDa, Claudia Kimble, APRNb, Mariann Pappagallo, MDb and Naveed Hussain, MDb

a Division of Pediatric Pulmonology, Connecticut Children's Medical Center, Hartford, Connecticut
b Division of Neonatology, Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut

OBJECTIVE. The purpose of this work was to determine whether oral prednisolone is effective in weaning infants with bronchopulmonary dysplasia, after 36 weeks' postmenstrual age, off supplemental oxygen and to identify factors associated with successful weaning.

METHODS. Data were abstracted from a standardized prospectively collected database at the John Dempsey Hospital NICU. Logistic regression and receiver operating curve analyses were used.

RESULTS. Of 385 infants, 131 (34%) received oral prednisolone and 254 (66%) did not. There was no significant difference in race, gender, birth weight, or gestational age between the groups receiving and not receiving oral prednisolone. Infants in the oral prednisolone group were more likely to have received previous dexamethasone therapy, had longer duration of mechanical ventilation, had longer length of hospital stay, and were more likely to be discharged from the hospital on oxygen. Of those in the oral prednisolone group, 63% responded to treatment. Pulmonary acuity score and PCO2 were the only parameters that remained significant on multiple logistic regression analyses. The oral prednisolone-responsive group had a lower pulmonary acuity score compared with the oral prednisolone-nonresponsive group. A pulmonary acuity score value of ≤0.5 had a sensitivity of 20% and specificity of 97.4%, with positive and negative predictive values of 94.1% and 42.1%, respectively. Capillary PCO2 values were significantly lower in the oral prednisolone-responsive group compared with the oral prednisolone-nonresponsive group. In predicting a successful response to oral prednisolone, a capillary PCO2 value of <48.5 mmHg had a sensitivity of 50% and specificity of 89.7%, with positive and negative predictive values of 89.1% and 51.8%, respectively.

CONCLUSIONS. Oral prednisolone therapy is effective in weaning off supplemental oxygen in a postterm infant with oxygen-dependent bronchopulmonary dysplasia who has a pulmonary acuity score of <0.5 and PCO2 of <48.5 mmHg. In addition, if a single course of prednisolone fails, there is no clear benefit of using multiple courses.


Key Words: BPD • prednisolone • oxygen therapy • outcome

Abbreviations: BPD—bronchopulmonary dysplasia • PMA—postmenstrual age • OP—oral prednisolone • No-OP—subjects who did not receive oral prednisolone • OP-R—subjects who responded to oral prednisolone therapy • OP-NR—subjects who did not respond to oral prednisolone therapy • PAS—pulmonary acuity score • FIO2—fraction of inspired oxygen • ROC—receiver operating curve • CI—confidence interval


Accepted Jul 5, 2007.

[Full Text of Bhandari et al.] [Reprint (PDF) Version of Bhandari et al.]


Abstract 13 of 18 back

 

Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants Exposed Prenatally to Dexamethasone Versus Betamethasone

Ben H. Lee, MD, MPH, MSCRa,b, Barbara J. Stoll, MDa, Scott A. McDonald, BSc, Rosemary D. Higgins, MDd for the National Institute of Child Health and Human Development Neonatal Research Network

a Division of Neonatal-Perinatal Medicine, Emory University School of Medicine, Atlanta, Georgia
b MidAtlantic Neonatology Associates, Morristown, New Jersey
c Research Triangle Institute, Research Triangle Park, North Carolina
d National Institute of Child Health and Human Development, Washington, DC

OBJECTIVE. We compared the development of adverse neurodevelopmental outcomes at corrected ages of 18 to 22 months for extremely low birth weight infants exposed prenatally to dexamethasone, betamethasone, or no steroid.

METHODS. Study infants were extremely low birth weight (401–1000 g) infants who were in the care of National Institute of Child Health and Human Development Neonatal Research Network centers between January 1, 2002, and April 30, 2003; they were assessed neurodevelopmentally at corrected ages of 18 to 22 months. Outcomes were defined as Bayley Scales of Infant Development-II Mental Development Index of <70, Bayley Scales of Infant Development-II Psychomotor Development Index of <70, bilateral blindness, bilateral hearing aid use, cerebral palsy, and neurodevelopmental impairment. Neurodevelopmental impairment was defined as ≥1 of the aforementioned outcomes.

RESULTS. A total of 1124 infants met entry criteria. There were no statistically significant associations between prenatal dexamethasone exposure and any follow-up outcome, compared with no prenatal steroid exposure. Prenatal betamethasone exposure was associated with reduced risks of hearing impairment and neurodevelopmental impairment and with increased likelihood of unimpaired status, compared with no prenatal steroid exposure. Compared with betamethasone, dexamethasone was associated with a trend for increased risk of Psychomotor Development Index of <70, increased risk of hearing impairment, and decreased likelihood of unimpaired status.

CONCLUSIONS. Prenatal betamethasone exposure was associated with increased likelihood of unimpaired neurodevelopmental status and reduced risk of hearing impairment at corrected ages of 18 to 22 months among extremely low birth weight infants, compared with prenatal dexamethasone exposure or no prenatal steroid exposure. Pending a randomized, clinical trial, it may be in the best interests of infants to receive betamethasone, rather than dexamethasone, when possible.


Key Words: prenatal glucocorticoid treatment • dexamethasone • betamethasone • extremely low birth weight • neurodevelopmental outcome

Abbreviations: BSID-II—Bayley Scales of Infant Development-II • CP—cerebral palsy • ELBW—extremely low birth weight • MDI—Mental Development Index • NICHD—National Institute of Child Health and Human Development • NDI—neurodevelopmental impairment • PDI—Psychomotor Development Index • PVL—periventricular leukomalacia • PDA—patent ductus arteriosus • CLD—chronic lung disease • ROP—retinopathy of prematurity • OR—odds ratio • CI—confidence interval • EGA—estimated gestational age • IVH—intraventricular hemorrhage


Accepted Jul 23, 2007.

[Full Text of Lee et al.] [Reprint (PDF) Version of Lee et al.]


Abstract 14 of 18 back

 

Prematurely Born Children Demonstrate White Matter Microstructural Differences at 12 Years of Age, Relative to Term Control Subjects: An Investigation of Group and Gender Effects

R. Todd Constable, PhDa, Laura R. Ment, MDb,c, Betty R. Vohr, MDd, Shelli R. Kesler, MDe, Robert K. Fulbright, MDa, Cheryl Lacadie, MDa, Susan Delancy, MDb, Karol H. Katz, MDb,f, Karen C. Schneider, MDb, Robin J. Schafer, MDa, Robert W. Makuch, MDf and Allan R. Reiss, MDe

a Departments of Diagnostic Imaging
b Pediatrics
c Neurology
f Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut
d Department of Pediatrics, Brown Medical School, Providence, Rhode Island
e Department of Psychiatry, Stanford University School of Medicine, Palo Alto, California

OBJECTIVE. The goal was to use diffusion tensor imaging to test the hypothesis that prematurely born children demonstrate long-term, white matter, microstructural differences, relative to term control subjects.

METHODS. Twenty-nine preterm subjects (birth weight: 600–1250 g) without neonatal brain injury and 22 matched, term, control subjects were evaluated at 12 years of age with MRI studies, including diffusion tensor imaging and volumetric imaging; voxel-based morphometric strategies were used to corroborate regional diffusion tensor imaging results. Subjects also underwent neurodevelopmental assessments.

RESULTS. Neurodevelopmental assessments showed significant differences in full-scale, verbal, and performance IQ and Developmental Test of Visual Motor Integration scores between the preterm and term control subjects. Diffusion tensor imaging studies demonstrated widespread decreases in fractional anisotropy (a measure of fiber tract organization) in the preterm children, compared with the control subjects. Regions included both intrahemispheric association fibers subserving language skills, namely, the right inferior frontooccipital fasciculus and anterior portions of the uncinate fasciculi bilaterally, and the deep white matter regions to which they project, as well as the splenium of the corpus callosum. These changes in fractional anisotropy occurred in subjects with significant differences in frontal, temporal, parietal, and deep white matter volumes. Fractional anisotropy values in the left anterior uncinate correlated with verbal IQ, full-scale IQ, and Peabody Picture Vocabulary Test-Revised scores for preterm male subjects. In addition, preterm male subjects were found to have the lowest values for fractional anisotropy in the right anterior uncinate fasciculus, and fractional anisotropy values in that region correlated with both verbal IQ and Peabody Picture Vocabulary Test-Revised scores for the preterm groups; these findings were supported by changes identified with voxel-based morphometric analyses.

CONCLUSIONS. Compared with term control subjects, prematurely born children with no neonatal ultrasound evidence of white matter injury manifest changes in neural connectivity at 12 years of age.


Key Words: diffusion tensor imaging • premature • language

Abbreviations: DTI—diffusion tensor imaging • FA—fractional anisotropy • ROI—region of interest • VBM—voxel-based morphometry • PPVT-R—Peabody Picture Vocabulary Test-Revised • VMI—Developmental Test of Visual Motor Integration • FSIQ—full-scale IQ • VIQ—verbal IQ


Accepted Jul 20, 2007.

[Full Text of Constable et al.] [Reprint (PDF) Version of Constable et al.]


Abstract 15 of 18 back

 

Clinical Utility of Echocardiography for the Diagnosis and Management of Pulmonary Vascular Disease in Young Children With Chronic Lung Disease

Peter M. Mourani, MDa, Marci K. Sontag, PhDb, Adel Younoszai, MDc, D. Dunbar Ivy, MDc and Steven H. Abman, MDd

a Divisions of Critical Care
c Cardiology
d Pulmonary Medicine, Pediatric Heart-Lung Center, Department of Pediatrics
b Department of Preventative Medicine and Biometrics, Children's Hospital and University of Colorado Denver School of Medicine, Denver, Colorado

OBJECTIVE. The goal was to determine the clinical utility of Doppler echocardiography in predicting the presence and severity of pulmonary hypertension in patients with chronic lung disease who subsequently underwent cardiac catheterization.

METHODS. A retrospective review of data for all patients <2 years of age with a diagnosis of bronchopulmonary dysplasia, congenital diaphragmatic hernia, or lung hypoplasia who underwent echocardiography and subsequently underwent cardiac catheterization for evaluation of pulmonary hypertension was performed. The accuracy of echocardiography in diagnosing pulmonary hypertension, on the basis of estimated systolic pulmonary artery pressure, was compared with the detection of pulmonary hypertension with the standard method of cardiac catheterization.

RESULTS. Thirty-one linked measurements for 25 children were analyzed. Systolic pulmonary artery pressure could be estimated in 61% of studies, but there was poor correlation between echocardiography and cardiac catheterization measures of systolic pulmonary artery pressure in these infants. Compared with cardiac catheterization measurements, echocardiographic estimates of systolic pulmonary artery pressure diagnosed correctly the presence or absence of pulmonary hypertension in 79% of the studies in which systolic pulmonary artery pressure was estimated but determined the severity of pulmonary hypertension (severe pulmonary hypertension was defined as pulmonary/systemic pressure ratio of ≥0.67) correctly in only 47% of those studies. Seven (58%) of 12 children without estimated systolic pulmonary artery pressure demonstrated pulmonary hypertension during subsequent cardiac catheterization. In the absence of estimated systolic pulmonary artery pressure, qualitative echocardiographic findings, either alone or in combination, had worse predictive value for the diagnosis of pulmonary hypertension.

CONCLUSION. As used in clinical practice, echocardiography often identifies pulmonary hypertension in young children with chronic lung disease; however, estimates of systolic pulmonary artery pressure were not obtained consistently and were not reliable for determining the severity of pulmonary hypertension.


Key Words: chronic lung disease • bronchopulmonary dysplasia • pulmonary hypertension • echocardiography • cardiac catheterization

Abbreviations: CLD—chronic lung disease • PH—pulmonary hypertension • sPAP—systolic pulmonary artery pressure • mPAP—mean pulmonary artery pressure • TRJV—tricuspid regurgitant jet velocity • BPD—bronchopulmonary dysplasia • CDH—congenital diaphragmatic hernia • PA—pulmonary artery • sBP—systemic systolic blood pressure: CI—confidence interval • RAP—right atrial pressure


Accepted Jul 21, 2007.

[Full Text of Mourani et al.] [Reprint (PDF) Version of Mourani et al.]


Abstract 16 of 18 back

 

Quality of Life of Formerly Preterm and Very Low Birth Weight Infants From Preschool Age to Adulthood: A Systematic Review

Jill Glennis Zwicker, MA, BA, BSc(OT), OT(C)a and Susan Richardson Harris, PhD, PTb

a Rehabilitation Sciences
b Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

OBJECTIVE. The goal of this systematic review was to synthesize studies that examined the health-related quality of life of preschool- and school-aged children, adolescents, and young adults who were born preterm and/or at very low birth weight.

METHODS. We searched 7 databases up to September 2006 (Medline, PubMed, Embase, EBM Reviews, Cumulative Index of Nursing and Allied Health Literature, PsycINFO, and the Educational Resource Information Center) as well as gray literature sources. We independently screened studies and included them only if a quality-of-life outcome measure was used and findings compared preterm, very low birth weight, or extremely low birth weight infants with term or normal birth weight peers. We independently assessed the methodologic quality of each study by using criteria adapted from the Centre for Reviews and Dissemination.

RESULTS. Fifteen cohort or cross-sectional studies met the review criteria. In 6 studies of preschool-aged children, differences were found between study and control groups, suggesting that many preschool children born preterm or at very low birth weight perform more poorly than their peers in physical, emotional, and/or social functioning. Extremely low birth weight school-aged children had lower health utility scores compared with their peers, and similar results were found for adolescents. Parents of preterm and very low birth weight teens noted significantly poorer performance in their child's global health, behavior, and physical functioning, whereas the teenagers themselves did not. In young adulthood, differences in physical functioning remained, but subjective quality of life was similar to normal birth weight peers.

CONCLUSIONS. The effects of preterm birth/very low birth weight on health-related quality of life seem to diminish over time, which possibly reflects issues related to a child's report versus a parent-proxy report, differing definitions of health-related quality of life, and adaptation of individuals over time, versus true change in health-related quality of life.


Key Words: extremely low birth weight • very low birth weight • health-related quality of life • quality of life • systematic review

Abbreviations: VLBW—very low birth weight • ELBW—extremely low birth weight • QoL—quality of life • HRQoL—health-related quality of life • NBW—normal birth weight • ELGA—extremely low gestational age


Accepted Jun 19, 2007.

[Full Text of Zwicker and Harris] [Reprint (PDF) Version of Zwicker and Harris]


Abstract 17 of 18 back

 

STATE-OF-THE-ART REVIEW ARTICLE

Etiologic Classification of Attention-Deficit/Hyperactivity Disorder

J. Gordon Millichap, MD, FRCP

Division of Neurology, Children's Memorial Hospital, Northwestern University Medical School, Chicago, Illinois

ABSTRACT

Attention-deficit/hyperactivity disorder is a neurobiological syndrome with an estimated prevalence among children and adolescents of 5%. It is a highly heritable disorder, but acquired factors in etiology are sometimes uncovered that may be amenable to preventive measures or specific therapy. Early reports have described symptoms similar to attention-deficit/hyperactivity disorder that followed brain trauma or viral encephalitis, and recent MRI studies have demonstrated brain volumetric changes that may be involved in the pathophysiology of the syndrome. The American Psychiatric Association's Diagnostic Statistical Manual, introduced in 1968, emphasizes symptomatic criteria in diagnosis. Here, an overview of environmental factors in the etiology of attention-deficit/hyperactivity disorder is presented to encourage more emphasis and research on organic causal factors, preventive intervention, and specific therapies. An organic theory and the genetic and biochemical basis of attention-deficit/hyperactivity disorder are briefly reviewed, and an etiologic classification is suggested. Environmental factors are prenatal, perinatal, and postnatal in origin. Pregnancy- and birth-related risk factors include maternal smoking and alcohol ingestion, prematurity, hypoxic-ischemic encephalopathy, and thyroid deficiency. Childhood illnesses associated with attention-deficit/hyperactivity disorder include virus infections, meningitis, encephalitis, head injury, epilepsy, toxins, and drugs. More controversial factors discussed are diet-related sensitivities and iron deficiency. Early prenatal recognition, prevention, and treatment of environmental etiologies of attention-deficit/hyperactivity disorder may reduce physician reliance on symptomatic modification with medication, a frequent reason for parental concern.


Key Words: attention deficit • hyperactivity • etiology • environmental • viral • nicotine • thyroid

Abbreviations: ADHD—attention-deficit/hyperactivity disorder • GRTH—generalized resistance to thyroid hormone


Accepted Jul 5, 2007.

[Full Text of Millichap] [Reprint (PDF) Version of Millichap]


Abstract 18 of 18 back

 

Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate

William A. Engle, MD and the Committee on Fetus and Newborn

Respiratory failure secondary to surfactant deficiency is a major cause of morbidity and mortality in preterm infants. Surfactant therapy substantially reduces mortality and respiratory morbidity for this population. Secondary surfactant deficiency also contributes to acute respiratory morbidity in late-preterm and term neonates with meconium aspiration syndrome, pneumonia/sepsis, and perhaps pulmonary hemorrhage; surfactant replacement may be beneficial for these infants. This statement summarizes indications, administration, formulations, and outcomes for surfactant-replacement therapy. The impact of antenatal steroids and continuous positive airway pressure on outcomes and surfactant use in preterm infants is reviewed. Because respiratory insufficiency may be a component of multiorgan dysfunction, preterm and term infants receiving surfactant-replacement therapy should be managed in facilities with technical and clinical expertise to administer surfactant and provide multisystem support.


Key Words: surfactant • antenatal steroids • respiratory distress syndrome • meconium aspiration syndrome • neonatal pneumonia • neonatal sepsis • congenital diaphragmatic hernia • pulmonary hemorrhage • persistent pulmonary hypertension • preterm • term

Abbreviations: RR—relative risk • CI—confidence interval • NNT—number needed to treat


[Full Text of Engle and and the Committee on Fetus and Newborn] [Reprint (PDF) Version of Engle and and the Committee on Fetus and Newborn]